As the synergistic effect of CLOCK and ATF4 has been implicated in multidrug resistance through glutathione-dependent redox system, a breakdown in this correlation could lead to differential drug response in human cancer (Igarashi et al., 2007). The gene discussed is CLOCK; the disease is cancer.